Skip to main content
Livermore
Livermore
ZHEN

Vanguard Group Inc

SEC CIK
0000102909
Latest filing
Jan 29, 2026

SAGE holding history

Sage Therapeutics, Inc. in every 13F filed by Vanguard Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SAGE overviewAll 13F holders of SAGEFull Q4 2025 holdings

Shares (Q3 2025)
0
Sold out in Q3 2025
Value
$0
% of portfolio
0.0%
Quarters held
18
Since Q1 2021
Holdings of SAGE by Vanguard Group Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20250$00.0%−3,265,802−100.0%Sold outHolders
Q2 20253,265,802$29.8M<0.1%−1,811,486−35.7%ReducedHolders
Q1 20255,077,288$40.4M<0.1%+239,119+4.9%AddedHolders
Q4 20244,838,169$26.3M<0.1%−922,280−16.0%ReducedHolders
Q3 20245,760,449$41.6M<0.1%−655,872−10.2%ReducedHolders
Q2 20246,416,321$69.7M<0.1%+664,948+11.6%AddedHolders
Q1 20245,751,373$107.8M<0.1%+432,013+8.1%AddedHolders
Q4 20235,319,360$115.3M<0.1%+111,358+2.1%AddedHolders
Q3 20235,208,002$107.2M<0.1%+175,565+3.5%AddedHolders
Q2 20235,032,437$236.6M<0.1%+52,666+1.1%AddedHolders
Q1 20234,979,771$209.0M<0.1%+94,219+1.9%AddedHolders
Q4 20224,885,552$186.3M<0.1%+97,687+2.0%AddedHolders
Q3 20224,787,865$187.5M<0.1%+45,026+0.9%AddedHolders
Q2 20224,742,839$153.2M<0.1%+117,836+2.5%AddedHolders
Q1 20224,625,003$153.1M<0.1%+46,762+1.0%AddedHolders
Q4 20214,578,241$194.8M<0.1%−253,028−5.2%ReducedHolders
Q3 20214,831,269$214.1M<0.1%+6,459+0.1%AddedHolders
Q2 20214,824,810$274.1M<0.1%+66,772+1.4%AddedHolders
Q1 20214,758,038$356.1M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.